“AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan”
November 12, 2026
“AstraZeneca (AZN), Britain’s biggest pharmaceutical company, said on Friday that its profit after tax rose 23% to $3.12 billion (€2.79bn) for the July to September period, driven largely by its cancer treatments.
That marks a sharp pick-up from the rise of just over 2% in the previous quarter. The firm also launched a plan to generate $1.5 billion (€1.34bn) in annual savings, which it intends to reinvest mainly in the drugs it has in development…”
https://finance.yahoo.com/healthcare/articles/astrazeneca-profit-jumps-23-cancer-121741364.html